Results 71 to 80 of about 9,872 (176)

Late Outcomes of Aortic Valve Replacement with Bioprosthesis and Mechanical Prosthesis

, 2021
Background Despite constant improvement and refinement of the prostheses, the decision between mechanical and biological valves for aortic valve replacement is still controversial.
Alice Lemos Morais (12654259), Auristela Isabel de Oliveira Ramos (4628422), Carlos Gun (7822958), Larissa Ventura Ribeiro Bruscky (12654256)   +3 more
core   +1 more source

Thrombosis of Bioprosthetic Aortic Valve: Is the Entire Arsenal Deployed?

Reviews in Cardiovascular Medicine
The proliferation of transcatheter aortic valve implantation has alerted clinicians to a specific type of prosthetic degeneration represented by thrombosis. The pathogenesis of this clinical or subclinical phenomenon, which can occur in up to 15% of both
Claudia Maria Loardi, Marco Zanobini, Emmanuelle Vermes, Maria Elisabetta Mancini, Anne Bernard, Christophe Tribouilloy   +5 more
doaj   +1 more source

Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates

Journal of Cardiovascular Development and Disease
Background: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients ...
Tomáš Toporcer, Štefan Lukačín, Andrea Kraus, Marián Homola, Anton Bereš, Michal Trebišovský, Denis Radótzy, Vilém Rohn, Adrián Kolesár   +8 more
doaj   +1 more source

Comparison of Surgical Treatment Outcomes in Patients with Symptomatic Severe Aortic Valve Stenosis Using the Perceval Sutureless Bioprosthesis Versus a Conventional Biological Valve

Journal of Cardiovascular Development and Disease
Objectives: This single-center retrospective comparative cohort study aimed to compare the outcomes of aortic valve replacement using a Perceval sutureless bioprosthesis versus a conventional stented bioprosthesis in patients with symptomatic severe ...
Dejan M. Lazović, Milica Karadžić, Filip Vučićević, Gorica Marić, Miloš Grujić, Ivana Đurošev, Mladen J. Kočica, Svetozar Putnik, Dragan Cvetković   +8 more
doaj   +1 more source

Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis

, 2015
WOS:000369045700015International audienceThe valve-in-valve (ViV) procedure is an option for patients with symptomatic structural degeneration of a bioprosthesis and excessive reoperative risk.
Harmouche, Majid, Leguerrier, Alain, Boulmier, Dominique, Soulami, Reda Belhaj, Thebault, Christophe, Verhoye, Jean-Philippe, Anselmi, Amedeo   +6 more
core   +1 more source

Fatores de risco hospitalar para implante de bioprótese valvar de pericárdio bovino Hospital risk factors for bovine pericardial bioprosthesis valve implantation

Arquivos Brasileiros de Cardiologia, 2007
FUNDAMENTO: Identificação de fatores de risco pré-operatórios na cirurgia cardíaca valvar visa melhor resultado cirúrgico pela possível neutralização de condições relacionadas com morbi-mortalidade aumentada.
Mateus W. De Bacco, João Ricardo M. Sant'Anna, Gustavo De Bacco, Roberto T. Sant'Anna, Marisa F. Santos, Edemar Pereira, Altamiro Reis da Costa, Paulo Roberto Prates, Renato A. K. Kalil, Ivo A. Nesralla   +9 more
doaj   +1 more source

Comparison of a novel mechanical valve versus stented bioprosthetic valves for isolated mitral valve replacement in patients older than 65 yearsCentral MessagePerspective

JTCVS Open
Objective: To compare early and long-term clinical outcomes of bioprosthetic versus mechanical (On-X) mitral valve replacement (MVR) in patients aged 65 years and older.
Antonio Piperata, MD, PhD, Carlo Mariani, MD, PhD, Giacomo Murana, MD, PhD, Elio Fabbri, PhD, Paola Rucci, PhD, Maria Francesca Scuppa, MD, Filippo Londi, MD, Edoardo Bianco, MD, Benedetta Guerrini, MD, Ivan Tammaro, MD, Ludovica Fabiani, MD, Margherita Careddu, MD, Marta Bellomare, MD, Silvia Snaidero, MD, Riccardo Nania, MD, Sabrina Castagnini, MD, Marta Di Carlo, MD, Valentina Orioli, MD, Gianluca Folesani, MD, Davide Pacini, MD, PhD   +19 more
doaj   +1 more source

Long‐Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of Fallot

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Tetralogy of Fallot repair results in late occurrence of pulmonary regurgitation, which requires pulmonary valve replacement in a large proportion of patients.
Lucia Cocomello, Marco Meloni, Filippo Rapetto, Mai Baquedano, Maria Victoria Ordoñez, Giovanni Biglino, Chiara Bucciarelli‐Ducci, Andrew Parry, Serban Stoica, Massimo Caputo   +9 more
doaj   +1 more source

Thromboaspiration of a left-sided bioprosthetic valve thrombosis by a mini-access: the Lausanne novel procedure

Frontiers in Cardiovascular Medicine
Left-sided bioprosthesis valve thrombosis (LSBVT) is a challenging complication necessitating invasive interventions. In this study, we introduce a novel, minimally invasive approach.
Ziyad Gunga, Vladimir Rubimbura, Denise Oberson, Pierre Monney, Xavier Bechtold, Zied Ltaief, Valentina Rancati, Eric Eeckhout, Matthias Kirsch   +8 more
doaj   +1 more source

Prosthetic Aortic Valves: Challenges and Solutions

Frontiers in Cardiovascular Medicine, 2018
Aortic Valve Disease (AVD) is the most common Valvular Heart Disease (VHD), affecting millions of people worldwide. Severe AVD is treated in most cases with prosthetic aortic valve replacement, which involves the substitution of the native aortic valve ...
Lucia Musumeci, Nicolas Jacques, Alexandre Hego, Alain Nchimi, Patrizio Lancellotti, Patrizio Lancellotti, Patrizio Lancellotti, Cécile Oury   +7 more
doaj   +1 more source